60 Degrees Pharmaceuticals prices $1.0 million private placement
The Nasdaq-listed vector-borne disease drugmaker sold shares and warrants at $1.74 per share, with H.C. Wainwright as placement agent.
SEC filing
Latest
1 story
Sign inSign in1 story
The Nasdaq-listed vector-borne disease drugmaker sold shares and warrants at $1.74 per share, with H.C. Wainwright as placement agent.
SEC filing